GRI
GRI
NASDAQ · Biotechnology

Gri Bio Inc

$2.39
+0.20 (+9.13%)
As of Feb 8, 2:33 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.03M 1.06M 807.5K
Net Income -278,352 -347,095 -248,556
EPS
Profit Margin -27.1% -32.7% -30.8%
Rev Growth +14.1% -2.0% +8.2%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 510.3K 584.8K 564.9K
Total Equity 2.32M 2.49M 2.42M
D/E Ratio 0.22 0.23 0.23
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -433,012 -468,823 -342,942
Free Cash Flow -135,403 -181,532 -119,491